Skip to main content
Year archive

Ascelia Pharma — 2021 filings

All 43 regulatory filings released by Ascelia Pharma (ACE) in 2021, sourced directly from the official regulator.

43 Filings
2021 Period
2021 filings (43)
Filing Released Lang
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-21 English
Nomination Committee appointed for AGM 2022 in Ascelia Pharma AB
Board/Management Information
2021-11-30 English
Valberedningen utsedd i Ascelia Pharma AB inför årsstämman 2022
AGM Information
2021-11-30 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-04 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-04 English
Ascelia Pharma tecknar kliniskt samarbetsavtal med Taiho Oncology, Inc. för utveckling av Oncoral i kombination med LONSURF®
Environmental & Social Information
2021-09-21 Swedish
Ascelia Pharma Signs Clinical Collaboration Agreement With Taiho Oncology, Inc. for the Development of Oncoral in Combination with LONSURF®
Legal Proceedings Report
2021-09-21 English
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-08-19 Swedish
Investor Presentation 2021
Investor Presentation
2021-08-19 English
Covid-19 extends recruitment period of SPARKLE study
Regulatory Filings
2021-08-18 English
Covid-19 förlänger rekryteringsperioden för SPARKLE-studien
Regulatory Filings
2021-08-18 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-12 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-12 English
Bulletin from the Annual General Meeting in Ascelia Pharma AB on 5 May 2021
AGM Information
2021-05-05 English
Kommuniké från årsstämma den 5 maj 2021 i Ascelia Pharma AB
AGM Information
2021-05-05 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-05-05 English
Antalet aktier och röster i Ascelia Pharma AB
Share Issue/Capital Change
2021-04-30 Swedish
Number of shares and votes in Ascelia Pharma AB
Share Issue/Capital Change
2021-04-30 English
Ascelia Pharma AB offentliggör prospekt avseende upptagande till handel av nyemitterade aktier på Nasdaq Stockholm
Capital/Financing Update
2021-04-15 Swedish
Ascelia Pharma AB publishes prospectus regarding admission to trading of newly issued shares on Nasdaq Stockholm
Share Issue/Capital Change
2021-04-15 English
Kommuniké från extra bolagsstämma i Ascelia Pharma AB
AGM Information
2021-04-13 Swedish
Bulletin from the extraordinary general meeting in Ascelia Pharma AB
AGM Information
2021-04-13 English
Nyemission och återköp av C-aktier för aktiesparprogram
Share Issue/Capital Change
2021-04-09 Swedish
Issue and repurchase of series C shares for share saving program
Share Issue/Capital Change
2021-04-09 English
KALLELSE TILL ÅRSSTÄMMA I ASCELIA PHARMA AB
AGM Information
2021-03-31 Swedish
NOTICE OF ANNUAL GENERAL MEETING IN ASCELIA PHARMA AB
AGM Information
2021-03-31 English
Antalet aktier och röster i Ascelia Pharma AB
Share Issue/Capital Change
2021-03-31 Swedish
Number of shares and votes in Ascelia Pharma AB
Share Issue/Capital Change
2021-03-31 English
Audit Report / Information 2020
Audit Report / Information FY 2020
2021-03-30 Swedish
Annual Report 2020
Annual Report FY 2020
2021-03-30 English
Kallelse till extra bolagsstämma i Ascelia Pharma AB
Proxy Solicitation & Information Statement
2021-03-17 Swedish
Notice of extraordinary general meeting in Ascelia Pharma
AGM Information
2021-03-17 English
Ascelia Pharma har genomfört en riktad nyemission om 200 miljoner kronor
Share Issue/Capital Change
2021-03-17 Swedish
Ascelia Pharma has carried out a directed new share issue raising SEK 200 million
Capital/Financing Update
2021-03-17 English
Ascelia Pharma intends to carry out a directed new share issue
Capital/Financing Update
2021-03-17 English
Ascelia Pharma avser genomföra en riktad nyemission
Capital/Financing Update
2021-03-17 Swedish
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-16 English
Interim / Quarterly Report 2020
Interim / Quarterly Report FY 2020
2021-02-16 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-15 English
Information regarding transfer of shares in Ascelia Pharma AB from CMC SPV
Share Issue/Capital Change
2021-01-14 English
Information avseende överlåtelse av aktier i Ascelia Pharma AB från CMC SPV
Share Issue/Capital Change
2021-01-14 Swedish
Ascelia Pharma presenterar klinisk utvecklingsplan för Oncoral som en ny cellgiftsbehandling
Regulatory Filings
2021-01-12 Swedish
Ascelia Pharma presents clinical development plan for Oncoral as a novel chemotherapy
Regulatory Filings
2021-01-12 English